Effects of Acarbose Versus Glibenclamide on MAGE and Oxidative Stress in Patients With Type 2 DM
Status:
Completed
Trial end date:
2009-01-01
Target enrollment:
Participant gender:
Summary
To compare effect of acarbose versus glibenclamide treatment on mean amplitude of glyclemic
excursion and oxidative stress in diabetes individuals who failed to control their glucose by
metformin therapy alone
Phase:
Phase 4
Details
Lead Sponsor:
Taichung Veterans General Hospital
Collaborators:
Changhua Christian Hospital Taipei Veterans General Hospital, Taiwan